ARTICLE | Company News
Bioject, ImmunoVaccine Technologies deal
June 9, 2008 7:00 AM UTC
The companies will assess the use of Bioject’s Bioject B2000 needle-free device for delivering ImmunoVaccine’s pandemic influenza vaccine in a preclinical study. If the results are positive, the comp...